These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 9062138
1. Transductional efficacy and safety of an intraperitoneally delivered adenovirus encoding an anti-erbB-2 intracellular single-chain antibody for ovarian cancer gene therapy. Deshane J, Siegal GP, Wang M, Wright M, Bucy RP, Alvarez RD, Curiel DT. Gynecol Oncol; 1997 Mar; 64(3):378-85. PubMed ID: 9062138 [Abstract] [Full Text] [Related]
6. erbB-2 knockout employing an intracellular single-chain antibody (sFv) accomplishes specific toxicity in erbB-2-expressing lung cancer cells. Grim J, Deshane J, Feng M, Lieber A, Kay M, Curiel DT. Am J Respir Cell Mol Biol; 1996 Sep; 15(3):348-54. PubMed ID: 8810638 [Abstract] [Full Text] [Related]
7. The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy. Barker SD, Coolidge CJ, Kanerva A, Hakkarainen T, Yamamoto M, Liu B, Rivera AA, Bhoola SM, Barnes MN, Alvarez RD, Curiel DT, Hemminki A. J Gene Med; 2003 Apr; 5(4):300-10. PubMed ID: 12692864 [Abstract] [Full Text] [Related]
13. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer. Rancourt C, Bergeron C, Lane D, Garon G, Piché A. Cytotherapy; 2003 Jun; 5(6):509-22. PubMed ID: 14660047 [Abstract] [Full Text] [Related]
14. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors. Indraccolo S, Habeler W, Tisato V, Stievano L, Piovan E, Tosello V, Esposito G, Wagner R, Uberla K, Chieco-Bianchi L, Amadori A. Cancer Res; 2002 Nov 01; 62(21):6099-107. PubMed ID: 12414634 [Abstract] [Full Text] [Related]
15. A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer. Buller RE, Runnebaum IB, Karlan BY, Horowitz JA, Shahin M, Buekers T, Petrauskas S, Kreienberg R, Slamon D, Pegram M. Cancer Gene Ther; 2002 Jul 01; 9(7):553-66. PubMed ID: 12082455 [Abstract] [Full Text] [Related]
16. Intratumoral administration of an adenovirus expressing a kinase dead form of ErbB-2 inhibits tumor growth. Palmer K, Sharan N, Emtage P, Gauldie J, Muller WJ, Wan Y. Gene Ther; 2002 Jul 01; 9(13):898-905. PubMed ID: 12080384 [Abstract] [Full Text] [Related]
17. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice]. Kong B, Wang W, Liu C, Ma D, Qu X, Jiang J, Yang X, Zhang Y, Jiang S. Zhonghua Yi Xue Za Zhi; 2002 Sep 10; 82(17):1207-10. PubMed ID: 12475412 [Abstract] [Full Text] [Related]